OBJECTIVE: Although it is well known that Parkinson's disease (PD) with dementia results in functional decline, little is known about the impact of mild cognitive impairment in PD (PD-MCI) on day-to-day functioning. METHOD: Forty-one individuals with PD-MCI, 56 PD patients with normal cognition (PD-NC), and 47 healthy older adults were administered two performance-based measures of instrumental activities of daily living (IADLs) that evaluated medication and financial management. Informants of the PD patients were also administered an IADL questionnaire. RESULTS: There were no significant differences between PD-NC and healthy older adults on the performance-based measures of medication and financial management. However, PD-MCI patients demonstrated significantly lower scores on the performance-based measures of medication and financial management compared with healthy older adults. PD-MCI patients were also impaired compared with PD-NC patients on performance-based medication management, but no difference between these groups was observed for ability to manage finances. Performance-based financial and medication management did not correlate with scores on neuropsychological measures in PD-MCI patients. PD-MCI and PD-NC patients showed comparable scores on the informant-based IADL questionnaire. CONCLUSIONS: Performance-based measures of IADLs, particularly medication management ability, are sensitive to subtle functional declines in PD-MCI. Although impairment in performance-based measures is associated with cognitive status in PD, IADLs may be a separate domain of functioning from cognitive functioning in PD-MCI as these measures did not correlate with performance on the neuropsychological measures. Overall, performance-based assessment of IADLs may add to the clinical evaluation of PD-MCI. PsycINFO Database Record (c) 2014 APA, all rights reserved.
OBJECTIVE: Although it is well known that Parkinson's disease (PD) with dementia results in functional decline, little is known about the impact of mild cognitive impairment in PD (PD-MCI) on day-to-day functioning. METHOD: Forty-one individuals with PD-MCI, 56 PDpatients with normal cognition (PD-NC), and 47 healthy older adults were administered two performance-based measures of instrumental activities of daily living (IADLs) that evaluated medication and financial management. Informants of the PDpatients were also administered an IADL questionnaire. RESULTS: There were no significant differences between PD-NC and healthy older adults on the performance-based measures of medication and financial management. However, PD-MCIpatients demonstrated significantly lower scores on the performance-based measures of medication and financial management compared with healthy older adults. PD-MCIpatients were also impaired compared with PD-NC patients on performance-based medication management, but no difference between these groups was observed for ability to manage finances. Performance-based financial and medication management did not correlate with scores on neuropsychological measures in PD-MCIpatients. PD-MCI and PD-NCpatients showed comparable scores on the informant-based IADL questionnaire. CONCLUSIONS: Performance-based measures of IADLs, particularly medication management ability, are sensitive to subtle functional declines in PD-MCI. Although impairment in performance-based measures is associated with cognitive status in PD, IADLs may be a separate domain of functioning from cognitive functioning in PD-MCI as these measures did not correlate with performance on the neuropsychological measures. Overall, performance-based assessment of IADLs may add to the clinical evaluation of PD-MCI. PsycINFO Database Record (c) 2014 APA, all rights reserved.
Authors: Catherine A Sumida; Emily J Van Etten; Francesca V Lopez; David P Sheppard; Eva Pirogovsky-Turk; Jody Corey-Bloom; J Vincent Filoteo; Steven P Woods; Paul E Gilbert; Maureen Schmitter-Edgecombe Journal: Arch Clin Neuropsychol Date: 2019-10-24 Impact factor: 2.813
Authors: Á Sánchez-Ferro; J Benito-León; E D Louis; I Contador; J Hernández-Gallego; V Puertas-Martín; F Bermejo-Pareja Journal: Acta Neurol Scand Date: 2017-03-05 Impact factor: 3.209
Authors: Rachael Purri; Laura Brennan; Jacqueline Rick; Sharon X Xie; Benjamin L Deck; Lana M Chahine; Nabila Dahodwala; Alice Chen-Plotkin; John E Duda; James F Morley; Rizwan S Akhtar; John Q Trojanowski; Andrew Siderowf; Daniel Weintraub Journal: Mov Disord Date: 2020-06-10 Impact factor: 10.338
Authors: Ondrej Bezdicek; Markéta Červenková; Tyler M Moore; Hana Stepankova Georgi; Zdenek Sulc; David A Wolk; Daniel A Weintraub; Paul J Moberg; Robert Jech; Miloslav Kopecek; David R Roalf Journal: Assessment Date: 2018-06-21
Authors: Laura Brennan; Andrew Siderowf; Jonathan D Rubright; Jacqueline Rick; Nabila Dahodwala; John E Duda; Howard Hurtig; Matthew Stern; Sharon X Xie; Lior Rennert; Jason Karlawish; Judy A Shea; John Q Trojanowski; Daniel Weintraub Journal: Parkinsonism Relat Disord Date: 2016-02-21 Impact factor: 4.891
Authors: Jennifer S Gewandter; William Dale; Allison Magnuson; Chintan Pandya; Charles E Heckler; Tatyana Lemelman; Breton Roussel; Rafa Ifthikhar; James Dolan; Katia Noyes; Supriya G Mohile Journal: J Geriatr Oncol Date: 2015-09-11 Impact factor: 3.599
Authors: Laura Brennan; Andrew Siderowf; Jonathan D Rubright; Jacqueline Rick; Nabila Dahodwala; John E Duda; Howard Hurtig; Matthew Stern; Sharon X Xie; Lior Rennert; Jason Karlawish; Judy A Shea; John Q Trojanowski; Daniel Weintraub Journal: Mov Disord Date: 2015-08-07 Impact factor: 10.338
Authors: Samantha K Holden; Luis D Medina; Brian Hoyt; Stefan H Sillau; Brian D Berman; Jennifer G Goldman; Daniel Weintraub; Benzi M Kluger Journal: Mov Disord Date: 2018-10-10 Impact factor: 10.338
Authors: Zanjbeel Mahmood; Ryan Van Patten; Marina Z Nakhla; Elizabeth W Twamley; J Vincent Filoteo; Dawn M Schiehser Journal: J Int Neuropsychol Soc Date: 2020-05-07 Impact factor: 2.892
Authors: Benjamin L Deck; Sharon X Xie; Gyujae Choi; Jacqueline Rick; Andrew Siderowf; Samuel Rudovsky; Alice Chen-Plotkin; John E Duda; James F Morley; Nabila Dahodwala; John Q Trojanowski; Daniel Weintraub Journal: Mov Disord Clin Pract Date: 2019-05-17